19 May 2013
Keywords: Roche, Alzheimer's disease, Gantenerumab, Amyloid plaques
Article | 12 October 2011
Swiss drug major Roche (ROG: SIX) says that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 October 2011
11 October 2011
17 May 2013
© 2013 thepharmaletter.com